Moderna Reports Third Quarter 2024 Financial Results and …
Nov 7, 2024 · Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates. Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03. Achieves year-to-date product sales of $2.2 billion; reiterates 2024 expected product sales of $3.0 to $3.5 billion.
Moderna Reports Third Quarter 2024 Financial Results and …
Moderna, Inc. Thu, Nov 7, 2024, 6:30 AM 17 min read. In This Article: MRNA. Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03. Achieves year-to ...
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand …
5 days ago · On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 billion. The company attributed the growth to higher sales in the U.S ...
Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong …
6 days ago · Moderna Inc (NASDAQ:MRNA) reported $1.9 billion in revenue for the third quarter, with a net income of $13 million. The company successfully reduced operating expenses by $500 million compared to ...
Moderna to Report Third Quarter 2024 Financial Results on …
Oct 17, 2024 · CAMBRIDGE, MA / ACCESSWIRE October 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 7, 2024 to report its third quarter 2024 financial results, and provide a corporate update.
Moderna (MRNA) earnings Q3 2024
Nov 7, 2024 · Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than...
Moderna reports surprise profit on higher-than-expected COVID …
Nov 7, 2024 · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The company brought in ...
Moderna stock gains on Q3 beat (update) (MRNA:NASDAQ)
Nov 7, 2024 · Maddie Meyer/Getty Images News. Shares of Moderna (NASDAQ:MRNA) traded ~7% higher in the premarket on Thursday after the company swung back to profits on better-than-expected revenue in Q3 thanks ...
Quarterly Results - Moderna
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates. Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03. Achieves year-to-date product sales of $2.2 billion; reiterates 2024 expected product sales of …
Moderna Turns To Profit In Q3; Backs FY24 Net Product Sales …
Nov. 7, 2024, 07:15 AM. (RTTNews) - Drug maker Moderna, Inc. (MRNA) reported Thursday that its third-quarter net income was $13 million, compared to a net loss of $3.63 billion a year ago ...